Zhengye Biotechnology Holding Limited (ZYBT)
Nasdaq: ZYBT · Pharmaceutical Preparations · Jilin · filing with the SEC since 2023
Who runs Zhengye Biotechnology Holding Limited
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Song Songlin
Co-Chief Executive Officer. First filing Jun 2026, latest Jun 25, 2026, 0 filings in all.
Officers reporting now
6
of 11 people with a filing in the last fifteen months
Directors reporting now
5
11 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Song Songlin | Co-Chief Executive Officer | Jun 2026 | Jun 25, 2026 | none |
| Wang Ping (Nmn) | Chief Financial Officer | Jun 2026 | Jun 25, 2026 | none |
| Cheng Yuhong (Nmn) | Vice General Manager | Jun 2026 | Jun 25, 2026 | none |
| Han Aiden | Co-Chief Executive Officer | Mar 2026 | Mar 18, 2026 | none |
| Liu Zhongyao | Chief Operating Officer | Mar 2026 | Mar 18, 2026 | none |
| Lian Wei | Vice General Manager | Mar 2026 | Mar 18, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Han Zhenfa | director | Jun 2026 | Jun 25, 2026 | none |
| Jiang Ping (Piji) | director | Jun 2026 | Jun 25, 2026 | none |
| Hu Qiyi | director | Apr 2026 | Apr 24, 2026 | none |
| Li Guohan (Nmn) | director | Apr 2026 | Apr 24, 2026 | none |
| Sun Wenhua | director | Mar 2026 | Mar 18, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.